It is widely utilized in clinical settings outside the United States for treating stroke victims, traumatic brain injuries (TBI), and early-onset Alzheimer's disease
Foundayo is an oral GLP-1 approved for weight loss that contains orforglipron as its active ingredient and can be taken at any time of day, with or without food
Since SFN is a potent activator of phase II antioxidant enzymes, like HO-1, Yu et al
India Issues Urgent GLP-1 Drug Safety Alert The Indian Pharmacopoeia Commission (IPC) has issued a public notice on 14 May calling on doctors, patients, and consumers to closely monitor and report any adverse reactions linked to semaglutide and other GLP-1 receptor agonists including dulaglutide, liraglutide, and tirzepatide
Its the star ingredient to making anti-aging creams and dark spot-correcting serums effective
ABSTRACT Severe alcohol-associated hepatitis (SAH) is the most aggressive form of alcohol-associated liver disease and is associated with very high short-term mortality